RhumbLine Advisers’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.81M Sell
500,856
-9,183
-2% -$115K 0.01% 1324
2025
Q4
$5.83M Sell
510,039
-14,144
-3% -$166K ﹤0.01% 1319
2025
Q3
$6.65M Sell
524,183
-17,607
-3% -$255K 0.01% 1282
2025
Q2
$8.6M Sell
541,790
-13,218
-2% -$198K 0.01% 1124
2025
Q1
$8.29M Sell
555,008
-13,241
-2% -$235K 0.01% 1100
2024
Q4
$10.8M Sell
568,249
-5,685
-1% -$120K 0.01% 1015
2024
Q3
$15.5M Sell
573,934
-18,558
-3% -$474K 0.01% 856
2024
Q2
$14.8M Buy
592,492
+173,729
+41% +$4.98M 0.01% 846
2024
Q1
$13.9M Sell
418,763
-51,687
-11% -$1.77M 0.01% 889
2023
Q4
$16.7M Buy
470,450
+32,053
+7% +$1.02M 0.02% 769
2023
Q3
$15M Sell
438,397
-8,340
-2% -$317K 0.02% 778
2023
Q2
$17.9M Buy
446,737
+3,811
+0.9% +$152K 0.02% 710
2023
Q1
$17.4M Buy
442,926
+2,052
+0.5% +$75.3K 0.02% 685
2022
Q4
$14M Buy
440,874
+12,504
+3% +$377K 0.02% 768
2022
Q3
$12.1M Buy
428,370
+4,654
+1% +$159K 0.02% 791
2022
Q2
$15.1M Buy
423,716
+1,416
+0.3% +$57.3K 0.02% 677
2022
Q1
$20.8M Buy
422,300
+6,919
+2% +$366K 0.03% 562
2021
Q4
$23.2M Buy
415,381
+1,806
+0.4% +$99.3K 0.03% 556
2021
Q3
$24M Buy
413,575
+1,704
+0.4% +$105K 0.03% 491
2021
Q2
$26.1M Sell
411,871
-18,852
-4% -$1.24M 0.03% 477
2021
Q1
$27.5M Sell
430,723
-50,943
-11% -$2.95M 0.04% 446
2020
Q4
$25.2M Buy
481,666
+1,943
+0.4% +$95.8K 0.03% 458
2020
Q3
$21M Sell
479,723
-1,608
-0.3% -$71.1K 0.03% 453
2020
Q2
$21.2M Sell
481,331
-36,067
-7% -$1.53M 0.04% 432
2020
Q1
$20.1M Buy
517,398
+56,077
+12% +$2.86M 0.04% 394
2019
Q4
$26.1M Buy
461,321
+30,614
+7% +$1.71M 0.04% 384
2019
Q3
$23M Buy
430,707
+30,918
+8% +$1.66M 0.04% 399
2019
Q2
$23.3M Buy
399,789
+2,666
+0.7% +$143K 0.04% 401
2019
Q1
$19.7M Sell
397,123
-54,833
-12% -$2.41M 0.04% 440
2018
Q4
$16.8M Sell
451,956
-13,912
-3% -$506K 0.04% 485
2018
Q3
$17.6M Sell
465,868
-7,920
-2% -$330K 0.03% 484
2018
Q2
$20.7M Buy
473,788
+13,434
+3% +$631K 0.04% 424
2018
Q1
$23.2M Sell
460,354
-21,795
-5% -$1.28M 0.05% 388
2017
Q4
$31.7M Buy
482,149
+8,193
+2% +$521K 0.06% 299
2017
Q3
$28.3M Buy
473,956
+5,617
+1% +$334K 0.06% 308
2017
Q2
$30.4M Sell
468,339
-5,504
-1% -$348K 0.07% 293
2017
Q1
$29.6M Buy
473,843
+64,648
+16% +$3.89M 0.07% 294
2016
Q4
$23.6M Buy
409,195
+53,473
+15% +$3.16M 0.06% 330
2016
Q3
$21.1M Sell
355,722
-41,339
-10% -$2.54M 0.06% 319
2016
Q2
$24.6M Sell
397,061
-1,295
-0.3% -$79.7K 0.07% 273
2016
Q1
$24.6M Buy
398,356
+144,016
+57% +$8.49M 0.08% 261
2015
Q4
$15.5M Buy
254,340
+4,656
+2% +$277K 0.05% 370
2015
Q3
$12.6M Sell
249,684
-7,133
-3% -$380K 0.04% 423
2015
Q2
$13.2M Sell
256,817
-2,012
-0.8% -$104K 0.04% 428
2015
Q1
$13.2M Buy
258,829
+59,822
+30% +$3.08M 0.04% 424
2014
Q4
$10.6M Sell
199,007
-777
-0.4% -$39.5K 0.03% 474
2014
Q3
$9.11M Sell
199,784
-16,277
-8% -$766K 0.03% 500
2014
Q2
$10.2M Sell
216,061
-18,216
-8% -$847K 0.03% 480
2014
Q1
$10.8M Sell
234,277
-1,691
-0.7% -$78.3K 0.03% 470
2013
Q4
$11.4M Sell
235,968
-15,046
-6% -$704K 0.03% 454
2013
Q3
$10.9M Sell
251,014
-11,002
-4% -$469K 0.03% 465
2013
Q2
$10.7M Buy
+262,016
New +$10.9M 0.03% 447

Other funds holding XRAY

RhumbLine Advisers's XRAY Position: Q1 2026 in Review

RhumbLine Advisers reduced its Dentsply Sirona (XRAY) stake by 1.8% in Q1 2026, selling an estimated $115K and leaving 500,856 shares worth $5.81M. The position accounts for 0.01% of the portfolio, ranked #1324.

RhumbLine Advisers first reported a position in XRAY in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.7M in Q4 2017. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • RhumbLine Advisers held 500,856 shares of Dentsply Sirona worth $5.81M as of Q1 2026.
  • RhumbLine Advisers sold 9,183 Dentsply Sirona shares in Q1 2026, an estimated $115K.
  • Dentsply Sirona made up 0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1324 holding.
  • RhumbLine Advisers first reported a position in Dentsply Sirona in Q2 2013 and has held it in 52 quarters since.
  • RhumbLine Advisers's Dentsply Sirona position peaked at $31.7M in Q4 2017.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.